Voxelotor improves red blood cell functionality in children with sickle cell anaemia: An ancillary study of the HOPE-KIDS 1 trial.
Satheesh ChonatEarl FieldsHannah Q BaratzAmanda WattMira PochronSandy DixonMargaret TondaClark BrownDavid ArcherPublished in: EJHaem (2024)
These findings suggest that voxelotor treatment is associated with reduced RBC sickling and haemolysis in children with SCD.